Package Level Nondestructive Analysis Patents: Who Leads 2026
- 50.9% concentration at the top. The five leading assignees hold 163 of the 320 records in scope, but filings past that group thin out into a long tail of single- and double-digit filers.
- Filing activity has flattened, not fallen. Complete-year counts show 2021 and 2024 both at 6 filings — 0% change over that span — after a 2017 peak of 18; 2025-2026 counts are still filling in under the usual publication lag.
- G01N dominates, but A61B and B01L carry real weight. 67.5% of records sit in material analysis and testing (G01N), while 22.5% also touch diagnosis and surgery (A61B) and 16.6% touch lab apparatus (B01L) — signalling cross-over into diagnostic and lab-on-chip inspection claims.
Filing growth compares 2021 (6 records) with 2024 (6) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 320 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
Package level nondestructive analysis sits at the intersection of failure analysis and inspection metrology: scanning acoustic microscopy, X-ray tomography and acoustic micro imaging used to find delamination, voiding in solder and wire sweep without opening the package. The 320 records in scope span 2015 through the 2026 cut-off and are drawn from filings that pair an imaging modality with a specific defect-detection or interpretation problem — resolution limits, sample orientation and artifact interpretation among them.
Filing offices are concentrated in the United States, with Europe and the WIPO PCT route the next largest gateways, followed by smaller counts in Australia, Israel and Japan. That distribution points to a field still filed defensively in home and treaty jurisdictions rather than broadly localised worldwide.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 320 records: how filing activity has moved year over year, and which IPC subclasses the claims actually sit in.
Filing trend, 2017-2026
Filings peaked at 18 in 2017 and have since settled into a lower, flatter band; 2021 and 2024 both post 6 filings, a 0% change across that span. The final one or two years in the series are undercounted because publication trails filing by roughly 18 months.
IPC subclass composition
G01N (material analysis and testing) anchors the field at 67.5% of the 320 records. A61B (22.5%) and B01L (16.6%) show meaningful overlap into diagnostic and lab-apparatus claims, while G01T, C12Q, C12M, H01J and G06F each account for single-digit shares — evidence of a field that borrows imaging and metrology concepts from adjacent diagnostic domains rather than staying siloed in pure materials testing.
Shares are the percentage of the 320 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Package Level Nondestructive Analysis with Eureka
This page is one run against one query. Ask Eureka your own question about package level nondestructive analysis and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited records
X-ray compatibility metric for design-for-inspection of integrated circuit packages (US20250085240A1)
A method and system for determining compatibility of integrated circuit packages with X-ray inspection: deriving packaging and imaging specifications, building an X-ray discernability model from image samples and simulations, and using that model to set threshold values for design-for-inspection (DFI) parameters and assign compatibility scores against a target package type.Filed by University of Florida Research Foundation; published 2025-03-13.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US8435738B2 | Systems and methods for multi-analysis | 312 |
| 2 | US20140234949A1 | Systems and methods for fluid and component handling | 263 |
| 3 | US20130078624A1 | Systems and methods for multi-purpose analysis | 263 |
| 4 | US20030182246A1 | Applications of fractal and/or chaotic techniques | 261 |
| 5 | US20140296089A1 | Systems and methods for multi-analysis | 256 |
| 6 | WO2013052318A1 | Systems and methods for multi-analysis | 249 |
| 7 | US20140170735A1 | Systems and methods for multi-analysis | 216 |
| 8 | US4891829A | Method and apparatus for utilizing an electro-optic detector in a microtomography system | 206 |
| 9 | US20140073043A1 | Systems and methods for multi-analysis | 194 |
| 10 | US20130078625A1 | Fluid handling apparatus and configurations | 188 |
Citation counts favour older filings simply because they have had longer to accumulate citations inside the searched corpus; treat them as a signal of influence on the field rather than of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three read-outs from the concentration, trend and composition data that matter more than the raw counts on their own.
A crowded top, a long tail beneath it
The five leading assignees hold 163 of the 320 records in scope, and the tenth-ranked assignee already sits at just 8 records. Anyone entering this space is filing against a small group of dense portfolios plus 80-plus smaller filers, not a single dominant blocker.
Flat, not declining, filing activity
Filing counts held at 6 in both 2021 and 2024 after a 2017 peak of 18. Because publication lags filing by roughly 18 months, the apparent drop-off after 2024 should not be read as a real slowdown yet.
Materials testing carries the field, diagnostics leans in
Two-thirds of records sit in G01N, but more than a fifth also carry an A61B diagnosis-and-surgery class and a sixth carry a B01L lab-apparatus class. That overlap suggests claim drafters are increasingly bridging package inspection with diagnostic and lab-on-chip apparatus language.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to package level nondestructive analysis, with the prior art for and against each one.
Who is filing, and where the gaps sit
The leader board is short relative to the tail: a handful of related entities account for half the records, while dozens of single-digit filers hold the rest.
One filer well ahead of the field
The top-ranked assignee holds 89 of the 320 records, more than six times the count at fifth place (13). Its portfolio is tightly linked to related entities that co-file with it, which concentrates freedom-to-operate risk in one cluster rather than spreading it evenly.
A fast drop-off after the top five
Filing counts fall from 13 at fifth place to 8 at tenth, and the ranking runs to 92 assignees in total. Most of that ranking sits in single-digit territory, which is typical of a field built on specific defect-detection techniques rather than platform-level dominance.
Related-entity filing patterns
The strongest co-assignee pairing appears 12 times, and two other pairings involving the same cluster of related entities appear 8 times each. This pattern is consistent with corporate restructuring or IP holding-company arrangements rather than arm's-length co-invention.
| Assignee | Recent year | YoY |
|---|---|---|
| Theranos, Inc. | 0 | — |
| Labrador Diagnostics LLC | 0 | — |
| Theranos IP Company, LLC | 0 | — |
| HOLMES ELIZABETH | 0 | — |
| ExxonMobil Technology & Engineering Company | 0 | — |
| Carl Zeiss X-ray Microscopy, Inc. | 0 | — |
| New Jersey Institute of Technology | 0 | — |
| Nestec S.A. | 0 | — |
Where to take this analysis
The dataset points to specific next questions rather than a single answer; each depends on what the reader is trying to protect or clear.
Check freedom-to-operate against the top cluster
With 50.9% of records held by five related assignees, a freedom-to-operate review should map the co-assignee relationships before assuming the field is fragmented.
Explore assignee relationships in EurekaWatch the under-claimed detection sub-areas
Wire sweep detection, sample-orientation correction and artifact interpretation carry far fewer filings than the core material-analysis claims, suggesting room for a defensible first claim.
Run a white space search in EurekaRe-check the trend once 2025-2026 fill in
The 2021-2024 flat trend is the most reliable read available now; revisit filing momentum once publication lag closes the gap on the most recent two years.
Track filing trends in EurekaCommon questions about this landscape
It covers inspection techniques applied to a sealed integrated circuit or component package without opening or destroying it, chiefly scanning acoustic microscopy, X-ray tomography and acoustic micro imaging. In this dataset the search pairs those modalities with specific defect or interpretation problems: delamination detection, voids in solder, wire sweep, resolution limits, sample orientation and artifact interpretation. That combination is what separates this landscape from general X-ray or acoustic imaging patents that are not tied to package-level defect analysis.
The ranking covers 92 assignees drawn from the 320 records in scope, with the single leading assignee holding 89 records and the top five combined holding 163 records, or 50.9% of the total. Several of the top holders are related entities that co-file together, which concentrates the leading position within one corporate cluster rather than spreading it across independent competitors. Beyond the top ten, which together hold 66.9% of records, the remaining assignees each hold a small number of filings.
Filing counts peaked at 18 in 2017 and have since settled lower, with complete-year data showing 6 filings in both 2021 and 2024 — a 0% change across that span. That reads as flat rather than declining. The most recent one to two years in any such trend are always understated because publication typically lags actual filing by roughly 18 months, so it is too early to call the 2025-2026 dip a real slowdown.
Start with G01N, material analysis and testing, which covers 67.5% of the 320 records in scope and anchors the core inspection-technique claims. Then check A61B (22.5%) and B01L (16.6%), since a meaningful share of records also carry diagnostic or lab-apparatus classifications, which suggests claim language sometimes crosses from pure package inspection into diagnostic or lab-on-chip apparatus. Smaller classes like G01T, C12Q, C12M, H01J and G06F are worth a secondary pass rather than a first-pass search.
The concentration data shows half of all records held by five related assignees, but the specific defect-detection sub-areas — wire sweep detection thresholds, sample-orientation correction, and artifact interpretation methods for acoustic micro imaging — carry noticeably thinner coverage than the core material-analysis claims. That gap suggests room for narrowly scoped claims tied to a specific defect signature or correction algorithm rather than a broad imaging-modality claim, which is far more likely to run into the dense prior art held by the leading cluster.
Research Package Level Nondestructive Analysis in depth with Eureka
Go past this page: query the whole package level nondestructive analysis corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.